Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS

Recruiting now · Phase 1

Conditions studied: Polycystic Ovary Syndrome (PCOS), Polycystic Ovary Syndrome, PCOS

In brief

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.

Key facts

Study ID

NCT06143527

Run by

The Foundation for Orthopaedics and Regenerative Medicine

People needed

20

Starts

2023-11-16

Expected to finish

2027-11-16

Last updated by the study team

2025-04-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Ultrasound documented poly cystic ovary syndrome

You may not qualify if…

• Active infection
• Active cancer
• Chronic multisystem organ failure
• Pregnancy
• Clinically significant abnormalities on pre-treatment laboratory evaluation
• Medical condition that would (based on the opinion of the investigator) compromise patient's safety
• Continued drug abuse
• Previous organ transplant
• Hypersensitivity to sulfur
• Inability to supply proper informed consent

Where it is running

• Medical Surgical Associates Center — St John's, Antigua and Barbuda (enrolling)
• Athens Beverly Hills Medical Group — Glyfada, Greece (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.